GENE ONLINE|News &
Opinion
Blog

Cancer Immunotherapy
Partnerships Takeda PharmaceuticalF-starBispecific Antibody
F-star Announces Collaboration with Takeda to Develop Next Generation Immunotherapeutics
2023-07-09
Trials & Approvals Incyte CorporationAnti-PD-1
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
2023-03-23
R&D Cancer Immunotherapy
Combining STING Agonists and pHLIPs to Enhance Cancer Treatments
2022-11-09
Trials & Approvals Cancer ImmunotherapyRoche
Cancer Immunotherapy Phase III Trial Yields Positive Results
2022-08-02
Trials & Approvals Cancer
First Patient Dosed in Anti-tumor Clinical Trial
2022-07-29
Trials & Approvals Oncology
Cancer Research UK and Sosei Heptares Set for First Human Trial of EP4 Antagonist
2022-07-22
Licensing Antibody-Drug Conjugate
Astellas and Sutro Team Up for Immunostimulatory Antibody-Drug Conjugates (iADCs)
2022-06-28
Licensing China
Organon Licenses Biosimilars From Shanghai’s Henlius For $103 Million
2022-06-14
R&D Cancer
Vaccines Against Cancers May Be the Future
2022-05-30
Trials & Approvals Johnson & Johnson
Janssen’s First Cell Therapy Gets Europe’s Approval for Multiple Myeloma
2022-05-27
Trials & Approvals Merck
EU Expands Merck’s Keytruda Use on Breast Cancer
2022-05-25
Funding Immune Checkpoint Inhibitor
Pheast Gets a $76 Million Series A to Feed Pipeline of Immune Checkpoint Inhibitors
2022-04-27
Feature Blood CancerCancer Immunotherapy
ASH 2021: 4 Immunotherapies Highlight Transformations in Blood Cancer Treatment
2021-12-13
R&D
Gilead’s CAR-T Drug Outperforms Standard of Care in B-Cell Lymphoma Trial
2021-06-29
Trials & Approvals Checkpoint Inhibitor
Another Checkpoint Inhibitor Set to Make Market Appearance as FDA Grants Priority Review
2021-01-25
1 2
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top